Advancing Immunotherapies with Scalable HSC Expansion

Thank you - Your Download is Available Below

Advancing Immunotherapies with Scalable HSC Expansion

PDF | 804.1 KB

Download

Advancing Immunotherapies with Scalable HSC Expansion

How ImmuneBridge established a scalable, donor-independent platform for HSC-derived immune cell therapies.

Clear form data

Please Complete the Form

First Name *

Last Name *

E-Mail *

Phone Number *

Company *

Job Title *

Address *

Country *

Postal Code *

I would like to sign up for newsletters from Sartorius (Sartorius AG and its affiliated companies) based of my personal interests.
I can revoke my consent at any time with effect for the future by sending an e-mail to unsubscribe@sartorius.com or by clicking on the "unsubscribe" link in e-mails I have received.

* These fields are required Information on the use of your data can be found in our privacy policy

Thank you - Your Download is Available Below

Advancing Immunotherapies with Scalable HSC Expansion

Advancing Immunotherapies with Scalable HSC Expansion

Please Complete the Form

Complete Form to Access the File